Isoray - Innovative Brachytherapy
International Journal of Radiation Oncology Biology Physics
The determination of radiobiologically optimized half-lives for radionuclides used in permanent brachytherapy implants.
Authors: Armpilia CI, Dale RG, Coles IP, Jones B, Antipas V.
Published: 01/02/2003

“Cesium provides everything we want for prostate brachytherapy as both a monotherapy and in combination therapy, including delivery of a high dose of radiation more quickly for high risk patients in a low dose rate ‘setting.’” 

Dr. Bernard W. Taylor, MD

Texas Oncology - Longview Cancer Center